Sangamo Therapeutics, Inc. SGMO Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sangamo Therapeutics, Inc. SGMO

SGMO 0.530

+7.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scott_jiminez who wrote (46)	8/26/2000 12:14:48 PM
From: Biomaven	of 368

Thanks, Scott - that was very helpful. Hard to know how much (if any) of their present market cap is attributable to the distant potential for therapeutic use of their technology. Presumably activating the chromatin is an issue for other attempts at gene promotion as well? Who are the other players attempting to mudulate gene transcription? I think TKTX has some technology here, but my recollection may be wrong. Does any of the ARIA technology have application to endogenous genes? Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next